tiprankstipranks
NKGen Biotech (NKGN)
OTHER OTC:NKGN
US Market
NKGN
NKGen Biotech
RESEARCH TOOLSreports

NKGen Biotech (NKGN) Income Statement

120 Followers

NKGen Biotech Income Statement

Last quarter (Q1 2025), NKGen Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, NKGen Biotech's net income was $15.35M. See NKGen Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 77.00K$ 426.00K
Gross Profit
$ 0.00$ 0.00$ 59.00K$ 396.00K
Operating Expenses
$ 26.97M$ 29.75M$ 24.41M$ 22.26M
Depreciation and Amortization
$ 0.00$ 1.20M$ 1.21M$ 1.24M
EBITDA
$ -26.97M$ -81.00M$ -23.23M$ -20.70M
Operating Income
$ -26.97M$ -29.75M$ -24.35M$ -21.86M
Other Income/Expenses
$ -17.27M$ -53.20M$ -2.40M$ -1.40M
Pretax Income
$ -44.23M$ -82.95M$ -26.75M$ -23.26M
Net Income
$ -44.29M$ -82.95M$ -26.75M$ -23.27M
Per Share Metrics
Basic EPS
$ -1.54$ -5.38$ -1.25$ -1.08
Diluted EPS
$ -1.54$ -5.38$ -1.25$ -1.08
Weighted Average Shares Outstanding
 28.83M 15.43M 21.45M 21.45M
Weighted Average Shares Outstanding (Diluted)
 28.83M 15.43M 21.45M 21.45M
Currency in USD

NKGen Biotech Earnings and Revenue History